Subject: 2022 BPCA Priority List of Needs in Pediatric Therapeutics – Request for Nominations
Good morning,
The Eunice
Kennedy Shriver National
Institute of Child Health and Human Development
invites all stakeholders, including physicians, clinicians,
researchers, pediatric organizations and associations, patient
representatives, and other interested parties, to submit nominations
for pediatric research for the Best Pharmaceuticals for Children Act
(BPCA) program.
Please submit your nominations at the
following
link:
https://www.surveymonkey.com/r/BPCAPrioritization2022
You may
submit the form multiple times if you would like to enter more than
one nomination. Nominations will be accepted through June 1,
2022.
Nominations
for the BPCA Priority List of Needs in Pediatric
Therapeutics are solicited in order to enhance a program for
pediatric drug testing and development as outlined in the BPCA
legislation. The Priority List consists of key therapeutic needs
in the medical treatment of children and adolescents; it is organized
by Therapeutic Area, which can be a group of conditions, a subgroup
of the population, or a setting of care.
All nominations received will be considered and evaluated based on set criteria by leading pediatric experts and stakeholder representatives. The final Priority List will be published in the Federal Register and posted on the BPCA website as it sets the agenda for NICHD’s focus on future BPCA-related activities.
For further
detail, please see the Request for Information (RFI) at [LINK
PENDING].
Please
contact bpca@infinityconferences.com with
questions. We look forward to receiving your
nomination!
Regards,
Perdita Taylor-Zapata,
M.D.
BPCA Program
Lead
Eunice Kennedy Shriver National Institute of
Child Health and Human Development (NICHD)
National Institutes of Health
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Deborah Stein |
| File Modified | 0000-00-00 |
| File Created | 2023-08-27 |